{"pmid":32354654,"pmcid":"PMC7184016","title":"Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic.","text":["Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic.","Cont Lens Anterior Eye","Khavandi, Siamak","Tabibzadeh, Elsa","Naderan, Mohammad","Shoar, Saeed","32354654"],"journal":"Cont Lens Anterior Eye","authors":["Khavandi, Siamak","Tabibzadeh, Elsa","Naderan, Mohammad","Shoar, Saeed"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32354654","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.clae.2020.04.010","keywords":["conjunctivitis","corona virus-related conjunctivitis","covid-19"],"topics":["Case Report"],"weight":1,"_version_":1666138495211536386,"score":9.490897,"similar":[{"pmid":32295324,"title":"[Screening for novel coronavirus related conjunctivitis among the patients with corona virus disease-19].","text":["[Screening for novel coronavirus related conjunctivitis among the patients with corona virus disease-19].","Objective: Screening for novel coronavirus related conjunctivitis among the patients with coronavirus disease-19. Methods: Prospective series case study. Eighty-one patients diagnosed as coronavirus disease-19 in Guangxi Zhuang Autonomous Region People's Hospital were enrolled with ophthalmological consultation screening for novel coronavirus related conjunctivitis, including the inquiring of eye symptoms and checking for conjunctivitis-related signs. Conjunctival swab novel coronavirus nucleic acid test was performed on patients with clinical manifestation of conjunctivitis. Results: Only 3 of the 81 patients (3.70%) complained of eye discomfort, which appeared on the day 16.67+/-9.29 after the diagnosis of coronavirus disease-19. The eye signs did not meet the characteristics of viral conjunctivitis. Bilateral conjunctival swab novel coronavirus nucleic acid tests were negative. There was no evidence to support the diagnosis of novel coronavirus related conjunctivitis. Screening of clinical symptoms and signs of conjunctivitis in the remaining 78 patients showed no significant abnormalities. Conclusions: There wasn't any novel coronavirus related conjunctivitis in 81 patients with coronavirus disease-19.(Chin J Ophthalmol, 2020, 56:).","Zhonghua Yan Ke Za Zhi","Lan, Q Q","Zeng, S M","Liao, X","Xu, F","Qi, H","Li, M","32295324"],"abstract":["Objective: Screening for novel coronavirus related conjunctivitis among the patients with coronavirus disease-19. Methods: Prospective series case study. Eighty-one patients diagnosed as coronavirus disease-19 in Guangxi Zhuang Autonomous Region People's Hospital were enrolled with ophthalmological consultation screening for novel coronavirus related conjunctivitis, including the inquiring of eye symptoms and checking for conjunctivitis-related signs. Conjunctival swab novel coronavirus nucleic acid test was performed on patients with clinical manifestation of conjunctivitis. Results: Only 3 of the 81 patients (3.70%) complained of eye discomfort, which appeared on the day 16.67+/-9.29 after the diagnosis of coronavirus disease-19. The eye signs did not meet the characteristics of viral conjunctivitis. Bilateral conjunctival swab novel coronavirus nucleic acid tests were negative. There was no evidence to support the diagnosis of novel coronavirus related conjunctivitis. Screening of clinical symptoms and signs of conjunctivitis in the remaining 78 patients showed no significant abnormalities. Conclusions: There wasn't any novel coronavirus related conjunctivitis in 81 patients with coronavirus disease-19.(Chin J Ophthalmol, 2020, 56:)."],"journal":"Zhonghua Yan Ke Za Zhi","authors":["Lan, Q Q","Zeng, S M","Liao, X","Xu, F","Qi, H","Li, M"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32295324","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.3760/cma.j.cn112142-20200322-00213","keywords":["conjunctival swab viral nucleic acid test","conjunctivitis","novel coronavirus"],"locations":["Guangxi","swab"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138493237067776,"score":101.57256},{"pmid":32475104,"title":"Coronavirus Disease 2019 Presenting as Conjunctivitis.","text":["Coronavirus Disease 2019 Presenting as Conjunctivitis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The world is currently challenged to handle this pandemic. The common symptoms of COVID-19 are fever, cough, fatigue, and shortness of breath. There are few reports on the association of SARS-CoV-2 with ocular abnormalities including conjunctivitis. We report a case of a 54-year-old woman who presented solely with conjunctivitis subsequently diagnosed with COVID-19. A lack of full history of her travel abroad was another issue leading to a delay in evaluating her COVID-19 status that increased the infection risk to her managing team. Thus, primary care practitioners should be suspicious of this atypical feature of COVID-19, thus enabling us to identify such patients at entry points. Maintaining safety measures while managing patients is also crucial.","Korean J Fam Med","Ying, Ng Ying","Idris, Nur Suhaila","Muhamad, Rosediani","Ahmad, Imran","32475104"],"abstract":["Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The world is currently challenged to handle this pandemic. The common symptoms of COVID-19 are fever, cough, fatigue, and shortness of breath. There are few reports on the association of SARS-CoV-2 with ocular abnormalities including conjunctivitis. We report a case of a 54-year-old woman who presented solely with conjunctivitis subsequently diagnosed with COVID-19. A lack of full history of her travel abroad was another issue leading to a delay in evaluating her COVID-19 status that increased the infection risk to her managing team. Thus, primary care practitioners should be suspicious of this atypical feature of COVID-19, thus enabling us to identify such patients at entry points. Maintaining safety measures while managing patients is also crucial."],"journal":"Korean J Fam Med","authors":["Ying, Ng Ying","Idris, Nur Suhaila","Muhamad, Rosediani","Ahmad, Imran"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32475104","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.4082/kjfm.20.0090","keywords":["covid-19","conjunctivitis","coronavirus","severe acute respiratory syndrome coronavirus 2"],"topics":["Case Report"],"weight":1,"_version_":1668532089536905216,"score":98.10894},{"pmid":32377594,"pmcid":"PMC7201238","title":"Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2.","text":["Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2.","Purpose: To describe the multiplicity of ocular manifestations of COVID-19 patients, we report a case of pseudomembranous and hemorrhagic conjunctivitis related with SARS-CoV-2 pneumonia in a patient of intensive care unit (ICU). Observations: A 63-year-old male was admitted in intensive care unit (ICU), seven days after the beginning of an influenza-like symptoms, to manage an acute respiratory syndrome related with SARS-CoV-2. Chest scan showed interstitial pneumonia with \"crazy paving\" patterns. At day 19, ocular examination at the patient's bed described petechias and tarsal hemorrhages, mucous filaments and tarsal pseudomembranous. Conjunctival scrapings and swabs did not identify any bacteria or virus. To our knowledge, we described the first case of pseudomembranous conjunctivitis in a COVID-19 patient. Conclusion and importance: Considering that SARS-CoV-2 is present in tears and conjunctival secretions, external ocular infections could be factors of infectious spreading. Physicians should be aware of late (>2 weeks) ocular complications in COVID-19 patients to prevent sequelae.","Am J Ophthalmol Case Rep","Navel, Valentin","Chiambaretta, Frederic","Dutheil, Frederic","32377594"],"abstract":["Purpose: To describe the multiplicity of ocular manifestations of COVID-19 patients, we report a case of pseudomembranous and hemorrhagic conjunctivitis related with SARS-CoV-2 pneumonia in a patient of intensive care unit (ICU). Observations: A 63-year-old male was admitted in intensive care unit (ICU), seven days after the beginning of an influenza-like symptoms, to manage an acute respiratory syndrome related with SARS-CoV-2. Chest scan showed interstitial pneumonia with \"crazy paving\" patterns. At day 19, ocular examination at the patient's bed described petechias and tarsal hemorrhages, mucous filaments and tarsal pseudomembranous. Conjunctival scrapings and swabs did not identify any bacteria or virus. To our knowledge, we described the first case of pseudomembranous conjunctivitis in a COVID-19 patient. Conclusion and importance: Considering that SARS-CoV-2 is present in tears and conjunctival secretions, external ocular infections could be factors of infectious spreading. Physicians should be aware of late (>2 weeks) ocular complications in COVID-19 patients to prevent sequelae."],"journal":"Am J Ophthalmol Case Rep","authors":["Navel, Valentin","Chiambaretta, Frederic","Dutheil, Frederic"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32377594","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.ajoc.2020.100735","keywords":["covid-19","conjunctivitis","external ocular infections","intensive care unit","pandemic","sars-cov-2"],"locations":["Physicians"],"topics":["Case Report"],"weight":1,"_version_":1666597097424551938,"score":80.91722},{"pmid":32323704,"title":"COVID-19 emergency in the cruise's ship: a case report of conjunctivitis.","text":["COVID-19 emergency in the cruise's ship: a case report of conjunctivitis.","Little is known about the Covid-19 transmission through ocular tissue, and more research needs to be carried out in order to confirm its ability to infect ocular tissue and its pathogenic mechanisms. Covid-19 may be detected in the tears and conjunctival secretions in novel coronavirus pneumonia patients with conjunctivitis. This case report shows a severe viral conjunctivitis in a patient diagnosed with Covid-19 on the Diamond Princess ship, characterized by both red, irritated and swollen eyes, with transparent serous secretions, conjunctival chemosis, pseudomembranes of fibrin and inflammatory cells on the tarsal conjunctiva accompanied by preauricular lymph nodes and enlarged submaxillaries.","Clin Ter","Salducci, M","La Torre, G","32323704"],"abstract":["Little is known about the Covid-19 transmission through ocular tissue, and more research needs to be carried out in order to confirm its ability to infect ocular tissue and its pathogenic mechanisms. Covid-19 may be detected in the tears and conjunctival secretions in novel coronavirus pneumonia patients with conjunctivitis. This case report shows a severe viral conjunctivitis in a patient diagnosed with Covid-19 on the Diamond Princess ship, characterized by both red, irritated and swollen eyes, with transparent serous secretions, conjunctival chemosis, pseudomembranes of fibrin and inflammatory cells on the tarsal conjunctiva accompanied by preauricular lymph nodes and enlarged submaxillaries."],"journal":"Clin Ter","authors":["Salducci, M","La Torre, G"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32323704","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.7417/CT.2020.2212","keywords":["covid-19","conjunctivitis","ship"],"topics":["Case Report"],"weight":1,"_version_":1666138493801201664,"score":79.379196},{"pmid":32330304,"title":"Conjunctivitis and COVID-19: a meta-analysis.","text":["Conjunctivitis and COVID-19: a meta-analysis.","There are sparse data in literature regarding conjunctivitis incidence in COVID-19 and its relationship with disease severity. The objective of this metanalysis was to assess the association between conjunctivitis and the severity of COVID-19 disease. METHODS: We performed a meta-analysis with studies that included patients with severe vs non-severe form of COVID-19 infection. Severe COVID-19 infection was defined as severe pneumonia, mortality, acute respiratory distress syndrome (ARDS), use of mechanical ventilation or Intensive Care Unit (ICU) treatment. RESULTS: Three studies, including 1167 patients, reported the incidence of conjunctivitis at admission to the hospital. The overall rate of conjunctivitis was 1.1%; it was 3% and 0.7% in severe and non-severe COVID-19 patients, respectively. Patients with severe COVID-19 had an increased incidence of conjunctivitis (O.R.:3.4; 95% C.I.:1.1-10.2; p=0.030). CONCLUSIONS: Conjunctivitis is more frequent in severe COVID and may be a warning sign of poor outcomes. This article is protected by copyright. All rights reserved.","J Med Virol","Loffredo, Lorenzo","Pacella, Fernanda","Pacella, Elena","Tiscione, Giulia","Oliva, Alessandra","Violi, Francesco","32330304"],"abstract":["There are sparse data in literature regarding conjunctivitis incidence in COVID-19 and its relationship with disease severity. The objective of this metanalysis was to assess the association between conjunctivitis and the severity of COVID-19 disease. METHODS: We performed a meta-analysis with studies that included patients with severe vs non-severe form of COVID-19 infection. Severe COVID-19 infection was defined as severe pneumonia, mortality, acute respiratory distress syndrome (ARDS), use of mechanical ventilation or Intensive Care Unit (ICU) treatment. RESULTS: Three studies, including 1167 patients, reported the incidence of conjunctivitis at admission to the hospital. The overall rate of conjunctivitis was 1.1%; it was 3% and 0.7% in severe and non-severe COVID-19 patients, respectively. Patients with severe COVID-19 had an increased incidence of conjunctivitis (O.R.:3.4; 95% C.I.:1.1-10.2; p=0.030). CONCLUSIONS: Conjunctivitis is more frequent in severe COVID and may be a warning sign of poor outcomes. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Loffredo, Lorenzo","Pacella, Fernanda","Pacella, Elena","Tiscione, Giulia","Oliva, Alessandra","Violi, Francesco"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330304","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25938","keywords":["covid","covid-19","sars","sars-cov-2","conjunctivitis"],"topics":["Treatment"],"weight":1,"_version_":1666138494618042369,"score":67.221954}]}